|17.18||-0.05 / -0.29%|
Data as of 3:59pm ET
|17.18||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 25.00, with a high estimate of 38.00 and a low estimate of 19.00. The median estimate represents a +45.52% increase from the last price of 17.18.
The current consensus among 7 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.